BTCY
vs
S&P 500
BTCY
S&P 500
Over the past 12 months, BTCY has underperformed S&P 500, delivering a return of -53% compared to the S&P 500's +12% growth.
Stocks Performance
BTCY vs S&P 500
Performance Gap
BTCY vs S&P 500
Performance By Year
BTCY vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Biotricity Inc
Glance View
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 55 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
